Open AccessFour-and-a-half LIM protein 1 promotes paclitaxel resistance in hepatic carcinoma cells through the regulation of caspase-3 activation
Author(s) -
Lei Zhou,
Lei Ding,
Jie Liu,
Yanan Zhang,
Xiaoli Luo,
Lichun Zhao,
Jun Ren
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.187304
Subject(s) - paclitaxel , gene knockdown , cancer research , apoptosis , oxaliplatin , in vivo , chemistry , hepatocellular carcinoma , biology , cancer , medicine , colorectal cancer , biochemistry , microbiology and biotechnology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide.